MLICM
AURA icon

Metropolitan Life Insurance Company (MetLife)’s Aura Biosciences AURA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,552
Closed -$12.2K – 210
2024
Q1 		$12.2K Hold
1,552
– – ﹤0.01% 2062
2023
Q4 		$13.8K Hold
1,552
– – ﹤0.01% 2068
2023
Q3 		$13.9K Hold
1,552
– – ﹤0.01% 2059
2023
Q2 		$19.2K Buy
1,552
+420
+37% +$4.49K ﹤0.01% 1956
2023
Q1 		$10.5K Sell
1,132
-148
-12% -$1.54K ﹤0.01% 2141
2022
Q4 		$13.4K Hold
1,280
– – ﹤0.01% 2176
2022
Q3 		$23.2K Hold
1,280
– – ﹤0.01% 1957
2022
Q2 		$18.1K Buy
+1,280
New +$21.2K ﹤0.01% 2087

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AURA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aura Biosciences (AURA) in Q2 2024, closing a stake of 1,552 shares — an estimated $12.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AURA in Q2 2022 and held it in 8 quarters. The position peaked at $23.2K in Q3 2022. 75 funds tracked by Wall St. Rank hold AURA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Aura Biosciences position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,552 Aura Biosciences shares in Q2 2024, an estimated $12.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Aura Biosciences in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Aura Biosciences position peaked at $23.2K in Q3 2022.
  • 75 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.